The regulator has officially abandoned these dangerous plans for self-selection of potent medicines. This victory belongs to everyone who spoke up to protect patient safety. Keep watching the upcoming pharmacy guidelines to ensure they hold the line on these standards.
November 7, 2013
Final supporters
The new pharmacy regulator, the General Pharmaceutical Council (GPhC) has publicly stated that its expertise is in regulation and not in pharmacy practice. Despite this admission, and the strong representations from representative bodies within the profession, it is proposing without consultation, to fundamentally change pharmacy practice in the way the most potent medicines are sold to the public.
We believe that selling potent medicines on an open display puts patient safety at risk and the GPhC’s proposals, which will enable P category medicines to be made available through self-selection, must be withdrawn.
Click here to read more about why the PDA are concerned about these proposals
Updates
Reached 5,000 supporters
October 6, 2013
October 5, 2013
The GPhC is paying attention to our momentum and we need to pass the 5,000 threshold to force a real response. Post this link to your Facebook timeline right now to get us over the line. Text three colleagues and tell them why open display of potent medicines threatens patient safety.
Reached 1,000 supporters
July 24, 2013
July 21, 2013
The GPhC is ignoring our professional warnings but they cannot ignore the growing public pressure. Email your local representative today and tell them that patient safety is not for sale.
Reached 100 supporters
July 18, 2013
July 17, 2013
We are approaching one hundred signatures and the GPhC is paying attention to the momentum of this campaign. Post the link to your Facebook page right now to keep this pressure building. Send a text to three colleagues and ask them to sign before the end of the day.
96 Comments
The idea of making P medicines available as self-selection assumes that the buyer understands the pros & cons, the effects & side effects, the indications & contra-indications of these medicines! But do they??
Patient safety is at risk if this goes ahead. Even some medicines that currently have GSL status are not safe if taken inappropriately, for example ibuprofen in patients with hypertension, CKD3, heart failure. This move will completely undermine the role of the pharmacist!
P-meds and its sensible access controls allow patient choice of medications that would otherwise only be available through prescription due to safety concerns.Losing this control would reduce this selection, thus wasting doctor time and increasing NHS budgets.
It will not improve patient safety. It will leave pharmacists even less time to provide services. There is a complete lack of understanding of the employee/employer relationship on the part of the GPhC
Bear in mind that there are many P medicines which until recently were POM. So any decision to to make P medicines self selection can be likened to making POM self selection. It is not safe for the public
I don't see any benefits to this idea and many drawbacks
Self selection of P medicines will create more problems than it will solve.
Share Petition
Don't stop at signing, share the petition link with friends to multiply our impact
Copy link or share directly
The regulator has officially abandoned these dangerous plans for self-selection of potent medicines. This victory belongs to everyone who spoke up to protect patient safety. Keep watching the upcoming pharmacy guidelines to ensure they hold the line on these standards.
November 7, 2013
Final supporters
The new pharmacy regulator, the General Pharmaceutical Council (GPhC) has publicly stated that its expertise is in regulation and not in pharmacy practice. Despite this admission, and the strong representations from representative bodies within the profession, it is proposing without consultation, to fundamentally change pharmacy practice in the way the most potent medicines are sold to the public.
We believe that selling potent medicines on an open display puts patient safety at risk and the GPhC’s proposals, which will enable P category medicines to be made available through self-selection, must be withdrawn.
Click here to read more about why the PDA are concerned about these proposals
Updates
Reached 5,000 supporters
October 6, 2013
October 5, 2013
The GPhC is paying attention to our momentum and we need to pass the 5,000 threshold to force a real response. Post this link to your Facebook timeline right now to get us over the line. Text three colleagues and tell them why open display of potent medicines threatens patient safety.
Reached 1,000 supporters
July 24, 2013
July 21, 2013
The GPhC is ignoring our professional warnings but they cannot ignore the growing public pressure. Email your local representative today and tell them that patient safety is not for sale.
Reached 100 supporters
July 18, 2013
July 17, 2013
We are approaching one hundred signatures and the GPhC is paying attention to the momentum of this campaign. Post the link to your Facebook page right now to keep this pressure building. Send a text to three colleagues and ask them to sign before the end of the day.
96 Comments
Patients will buy inappropriate medicines having been bombarded by advertising by the large manufacturers, having self-diagnosed, possibly incorrectly. Patients have asked many times for 'thrush' products when they actually have symptoms of cystitis.
The idea of making P medicines available as self-selection assumes that the buyer understands the pros & cons, the effects & side effects, the indications & contra-indications of these medicines! But do they??
Patient safety is at risk if this goes ahead. Even some medicines that currently have GSL status are not safe if taken inappropriately, for example ibuprofen in patients with hypertension, CKD3, heart failure. This move will completely undermine the role of the pharmacist!
P-meds and its sensible access controls allow patient choice of medications that would otherwise only be available through prescription due to safety concerns.Losing this control would reduce this selection, thus wasting doctor time and increasing NHS budgets.
It will not improve patient safety. It will leave pharmacists even less time to provide services. There is a complete lack of understanding of the employee/employer relationship on the part of the GPhC
Bear in mind that there are many P medicines which until recently were POM. So any decision to to make P medicines self selection can be likened to making POM self selection. It is not safe for the public
I don't see any benefits to this idea and many drawbacks
Self selection of P medicines will create more problems than it will solve.
Share Petition
Don't stop at signing, share the petition link with friends to multiply our impact
Petitions like this
Other petitions you might want to support
Scan to share
Anyone who scans this can sign the petition.
Patients will buy inappropriate medicines having been bombarded by advertising by the large manufacturers, having self-diagnosed, possibly incorrectly. Patients have asked many times for 'thrush' products when they actually have symptoms of cystitis.